Explore › Finding
Finding decline
Women with HIV and periconceptional non-dolutegravir antiretroviral exposure had higher risk of pregnancy loss compared to women without HIV, with adjusted risk ratios of 1.23 in MarketScan and 1.11 in Medicaid.
Effect sizeaRR 1.11
CI95% CI 1.07-1.15
ComparatorWomen without HIV
Effect summarydecline; aRR 1.11; CI: 95% CI 1.07-1.15

Connected entities

Interventions
non-dolutegravir antiretroviral drug exposure
Conditions
HIV
Outcomes
High risk pregnancy due to recurrent pregnancy loss
Populations
Women

Source

PMC10614030
Dolutegravir and pregnancy outcomes including neural tube defects in the USA during 2008–20: a national cohort study
Read on PMC → · View in graph →